Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid | 252916-29-3 | MFCD09743433 | >98.0% | 310.3 g/mol | C18H18N2O3 | 200 MG
SDP

Supplier:  Medchemexpress LLC HY10517200MG

Encompass_Preferred

Orantinib is a small-molecule, orally bioavailable receptor tyrosine kinase inhibitor that selectively inhibits VEGFR2, PDGFRβ, and FGFR1, blocking receptor autophosphorylation and angiogenesis. It is used in preclinical and clinical research for tumor growth inhibition and antiangiogenic studies. Chemical formula C18H18N2O3; molecular weight ~310.3 g/mol; CAS 252916-29-3.

  • Multi-target inhibition of VEGFR2, PDGFRβ, and FGFR1.
  • Orally bioavailable small molecule suitable for in vivo and in vitro studies.
  • Blocks receptor autophosphorylation and inhibits angiogenesis.
  • Applied in oncology and angiogenesis research applications.
  • High purity material appropriate for research use.

Catalog No. 50-002-43943


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.